Health
Healthy Returns: What activist Starboard’s $1 billion stake means for Pfizer
Jakub Porzycki | Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Tuesday! Pfizer‘s troubles may finally be coming to a head. Former executives of the pharmaceutical giant are backing a […]
Read More
Women’s health startup Maven Clinic closes funding at $1.7 billion valuation
Kate Ryder, CEO of Maven, speaking at the CNBC Changemakers Summit in New York on April 18th, 2024. Danielle DeVries | CNBC Maven Clinic, a health-care startup for women and families, announced Tuesday that it has closed a $125 million funding round at a $1.7 billion valuation. The company seeks to offer patients virtual care […]
Read More
CVS is under pressure and considering a break up. Here’s why that could be risky
A sign outside of a CVS pharmacy store on February 07, 2024 in Miami, Florida. Joe Raedle | Getty Images It’s time for a wellness check at CVS Health. Shares of the company are down more than 20% this year as it grapples with higher-than-expected medical costs in its insurance unit and pharmacy reimbursement pressure, […]
Read More
Oura announces new smart ring with updated design and new sensors for $349
A user wearing an Oura Ring Courtesy: Oura Oura unveiled its new smart ring, the Oura Ring 4, on Thursday, which is available starting at $349. The company’s rings track sleep, exercise, stress, heart health and other metrics to help users understand their bodies and make healthier choices. The Oura Ring 4 has new sensors, […]
Read More
Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
Source: Recursion Pharmaceuticals AI drug pioneer Recursion Pharmaceuticals said Wednesday that one of its experimental treatments hit a key milestone. Recursion was able to use its artificial intelligence-enabled drug discovery platform to identify an area of biology to target for the treatment of solid tumors and lymphoma, match it with a drug candidate and move […]
Read More
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly will spend $4.5 billion to build a center aimed at finding better ways to manufacture its medicines. The facility, called the Lilly Medicine Foundry, will house development of […]
Read More
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Kena Betancur | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Hello and happy Tuesday! Today, we’re unpacking a shocking move from Pfizer. The pharmaceutical giant last week announced it […]
Read More
CVS is working with advisors on strategic review, sources say
CVS Pharmacy logo is seen in Washington DC, United States on July 9, 2024. Jakub Porzycki | Nurphoto | Getty Images CVS Health‘s board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter, as the company contends with potential activist pressure and a severely depressed stock […]
Read More
GE Healthcare has been an under-the-radar winner — and a new catalyst just arrived
GE Healthcare ‘s quiet outperformance is becoming harder to tune out — and its new drug used in radiology to improve the diagnosis of heart disease can help the Club stock make some more noise. In a note to clients Sunday, Wells Fargo analysts said that GE Healthcare’s diagnostic agent Flyrcado is “possibly the most […]
Read More
Major CVS shareholder plans activist push, will meet with management, sources say
CVS Pharmacy logo is seen at store in Florida Keys, United States on May 7, 2024. Jakub Porzycki | Nurphoto | Getty Images Glenview Capital, a major CVS Health shareholder, is expected to meet with company leadership on Monday to lay out proposed fixes for the struggling business, according to people familiar with the matter, […]
Read More